---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-092166"
form_type: "8-K"
ticker: "ACXP"
cik: "0001736243"
company_name: "Acurx Pharmaceuticals, Inc."
filed_at: "2025-09-22T23:59:59+00:00"
generated_at: "2026-05-17T05:58:58.475292+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Acurx increases authorized common stock from 200 million to 250 million shares

## Summary
- Stockholders approved amendment at special meeting on September 16, 2025.
- Authorized common stock increased from 200,000,000 to 250,000,000 shares.
- Amendment filed with Delaware Secretary of State on September 22, 2025, effective immediately.
- Shares may be used for future capital raising, acquisitions, or other corporate purposes.

## SEC filing metadata
- accession: 0001104659-25-092166
- form_type: 8-K
- ticker: ACXP
- cik: 0001736243
- company_name: Acurx Pharmaceuticals, Inc.
- filed_at: 2025-09-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/0001104659-25-092166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/tm2526666d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-092166
- JSON: https://secwatch.observer/filing/0001104659-25-092166.json
- Plain text: https://secwatch.observer/filing/0001104659-25-092166.txt

## Key facts
- Governance Changes
  Acurx Pharmaceuticals, Inc.: Amendment to Certificate of Incorporation to increase authorized shares of common stock from 200,000,000 to 250,000,000 (effective 2025-09-22).
  - Change: charter amendment
  - Effective: 2025-09-22
  source text: the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s Certificate of Incorporation, as amended, to increase the total number of authorized shares of the Company’s common stock from 200,000,000 to 250,000,000. On September 22, 2025, the Company filed the Amendment with the Secretary of State of the State of Delaware with immediate effect.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/0001104659-25-092166-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.